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Abstract 
Background: The novel coronavirus SARS-CoV-2 disease, named “COVID-19" by the WHO, was declared Public 
Health Emergency Concern globally January 2020. As of 01 February, 2021, the virus already visited more than 200 
countries across the globe, with a total of over 103 million confirmed cases, over 2 million deaths and over 76 million 
recoveries.  
COVID-19 first appeared in the African continent on 15th February 2020 in Egypt. Back in April 2020, only a few 
African countries reported 1, 2 or 3 confirmed cases with no death; but as of 07 June the virus visited over 45 African 
countries already with a total of 183,474 confirmed cases, 81,367 recovered and 5,041 deaths. Moreover, country 
context evidence is important at least to reduce the impact of COVID 19 in Africa region.  
Objective: The objective is to get cohesive understanding on hospitalization, recovery, death, incubation period and 
severity of COVID-19.  
Methods: Systematic Review was carried out to synthesis cohesive information on hospitalization, recovery, death, 
incubation period and severity of the disease. This review includes a systematic literature search of PubMed and 
other sources like Google Scholar and Research Gate.  
Results: Hospitalization rate for young is as low as 1%, while it ranged from 20.7% to 31.4% for older people. 
Hospitalization rate was high among patients with obesity (Body Mass Index>40), and heart failure. Recovery rate 
ranged from 30% in China to over 70% in South Korea. Overall case fatality rate from different studies ranged from 
0.1% to 6%. But this value increases to as much as over 45% for those over 75 years old. The median incubation 
period ranged from 4 days to 5.1 days but showed increment for the older ages. Proportion of critically ill patients 
ranged from 0.026% to 23%. More severe cases were seen among males than females.  
Conclusion: This systematic review in-sight the variation in hospitalization, recovery, death, incubation period and 
severity of COVID-19 pertaining to patients’ characteristics. [Ethiop. J. Health Dev. 2021; 35(SI-1):76-81] 
Key words: Hospitalization, Recovery, Death, incubation period severity, COVID-19, systematic review 
 
Introduction  
An outbreak of “pneumonia of unknown etiology" in 
Wuhan, Hubei Province, China in early December 2019 
has spiralled into an epidemic that ravaged China and 
eventually developed to a pandemic state (1). The 
causative agent was argued to be a new beta-corona-
virus related to the Middle East Respiratory Syndrome 
virus (MERS-CoV) and the Severe Acute Respiratory 
Syndrome virus (SARS-CoV). The novel coronavirus 
SARS-CoV-2 disease, named “COVID-19" by the 
World Health Organization (WHO), was declared as 
Public Health Emergency Concern globally January 
2020 (2).  
 
In the beginning, China’s government lockdown Wuhan 
and suspended all public transport, flights and trains; by 
late January 2020, there were about 40,000 confirmed 
cases and 909 deaths (2.2%) as reported by the National 
Health Commission of China. During this period, 319 
cases and one death were reported in 24 other countries 
(3). 
 
The novel virus is transmitted from person to person by 
respiratory droplets and related routes, causing 
symptoms, among other things, like fever, cough, and 
shortness of breath after a period believed to range from 
2 to 14 days following infection (1, 4, 5). Preliminary 
studies suggest that old people with co-morbidities 
might be at higher risk for severe illness from COVID-
19 (4, 6, 7); but, exact virologic and epidemiological 
characteristics of this zoonotic human coronavirus are 
still the source of controversy.  
 
Methodology 
The review started by identifying PICOS (participants, 
interventions, comparators, outcomes, and study design) 
structure. It followed the five-step principle to conduct 
the systematic review, namely, i) Framing questions for 
a review, ii) Identifying relevant work, ii) Assessing the 
quality of studies, iV) Summarizing the evidence, and v) 
Interpreting the findings. 
 
Our protocol follows recommendations set out in the 
Statement of Preferred Reporting Items for Systematic 
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Records screened 
[n= 212]
Full-text articles assessed for 
eligibility 
[n=198 ]
Studies included in the synthesis
[n= 15]
Records after primary screening  
[n=3815 ]
Records excluded due 
to lack of information 
[n= 14]




excluded due to lack 
of information
[n=183 ]






























Figure 1. PRISMA (preferred reporting items for systematic reviews and meta-analyses) flowchart 
of study inclusions and exclusions. 
 
We included peer-reviewed and pre-print articles that 
reported hospitalization cases, case fatality rate, 
recovery rate, rate of infection, and COVID 19 severity. 
The article's language was English, and publications 
from January 1, to June 24, 2020 were included. 
Systematic reviews and meta-analysis studies, opinion 
articles and letters not presenting original data, as well 
as studies reporting cases with incomplete information 
were excluded. 
 
For the inclusion and exclusion criteria the full texts of 
the relevant articles were examined based on the 
PRISMA framework. The initial selection of search 
outcomes were first assessed by title and abstract. The 
researchers independently evaluated the search results 
by title and abstract based on the set eligibility criteria. 
The disagreement between the researchers were 
resolved by discussion. 
 
The searching strategy for PubMed was prepared using 
keywords from the study topic and searched by 
combining with Boolean operator OR/AND (Table 1).
  
Table 1: PubMed search result  
Search No Search query Result  
# 1  "COVID-19" [All Fields] OR "COVID" [All Fields] OR " Coronavirus" [All Fields] 
OR "SARS-CoV-2" [All Fields] OR "severe acute respiratory syndrome" [All 
Fields] Filters: from 2020/1/1 - 2020/6/30 
32,600 
# 2   severity [All Fields] Filters: from 2020/1/1 - 2020/6/30 63,042 
#3 "hospitalization rate" [All Fields] Filters: from 2020/1/1 - 2020/6/30 127 
#4 "death rate" OR "fatality rate" [All Fields] Filters: from 2020/1/1 - 2020/6/30 898 
#1 AND #2 
AND #3 
AND #4 
((("COVID-19" [All Fields] OR "COVID" [All Fields] OR " Coronavirus" [All 
Fields] OR "SARS-CoV-2" [All Fields] OR "severe acute respiratory syndrome" [All 
Fields] AND (2020/1/1:2020/6/30[pdat])) AND (severity [All Fields] AND 
(2020/1/1:2020/6/30[pdat]))) OR ("hospitalization rate" [All Fields] AND 
(2020/1/1:2020/6/30[pdat]))) OR ("death rate" OR "fatality rate" [All Fields] AND 
(2020/1/1:2020/6/30[pdat])) Filters: from 2020/1/1 - 2020/6/30 
8,333 
 
The quality of the articles included in the review was 
checked and rated with Critical Appraisal Checklist for 
Cross-Sectional Study by the team of the review to 
reduce the risk of bias(9).   
Basic characteristics of articles such as authors, name of 
publishing journal, time of publication, country of the 
study, study design, sample size, and quality score of the 
article were included. The extraction was performed by 
two reviewers and a third reviewer checked the accuracy 
of the extracted data. A principal investigator checked 
the articles list and data extractions to ensure the overall 
relevance of the included articles and the quality. 
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Initially, when search was conducted using keywords by 
applying the OR/AND Boolean operators, a total of 
8,333 search results were found from PubMed (Table 1). 
After filtering these result by article types, publication 
status (preprint/published), and language (English) a 
total of 3815 articles remained. We screened and filtered 
the articles further by reading the title and abstract where 
212 articles were selected for full-text assessment. Of 
these, 10 articles which fulfilled the inclusion criteria 
and contained relevant information were selected. We 
also identified 3 articles from the ResearchGate and 2 
articles from Google Scholar that fulfilled the inclusion 
criteria. So, a total of 15 articles were included for the 
final systematic review of qualitative synthesis.  
 
Results 
Studies search and characteristics  
Among these 15 studies, majority of them 8 were from 
China, 4 were from the USA and the remaining were one 
each from Brazil, Italy and South Korea (Table 2). The 
study subjects included a total of 114,018 cases ranging 
from 99 to 72,314 cases.  The study designs of the 
included studies were record review 4, cross-sectional 3, 
cohort 3, surveillance 1, report 1, case series 1 and others 
didn’t report the study design (Table 2).  
 
Table 2: Characteristics of the included studies  







NA 2020 USA  Report   Fair 24 
Chen N et al  Lancet  2020 China  Retrospective 
single centered 
study  
99 Fair  28 
Garg S et al  Preprint  2020 USA Surveillance  1482 fair 25 
Guan W et al  engl j med 2020 China  Cross-
sectional  
1099 Good  34 
Lauer SA et al  Ann Intern  
Med 
2020 China  Not reported  181 Fair  33 
Li R et al  Preprint  2020 USA Cross-
sectional 
19425 V.Good  37 
Petrilli CM Preprint  2020 USA Cross-
sectional 
4103 V.Good 23 
Ricardo A et al  Brasília 2020 Brazil  Not reported  Fair  27 
Wu Z et al JAMA 2020  China  Case series  72,314 Good 31 




2020 Italy  Prospective 
cohort  
233 Good 29 




2020 China  Retrospective 
cohort  
548 V.Good 26 
Shim E et al  Intern. Journal 
of Infectious 
Diseases 
2020 S.Korea Record review  6284 Fair 30 
Ye Q. et al  J Med Virol 2020 China  Record review 1099 Good  32 
Nie X et al  JID 2020 China  Retrospective 
record review  
7015 Good 35 
Kong T-k Aging Medicine  2020 China  Record review  136 Fair 36 
 
From the articles reported sex, 53.98% were male with 
variations from 50.49% in USA to 69.1% in Italy. The 
median age across the studies were 52.13 years old, 
ranging from 47 years in China to 61 years in Italy.  
 
Hospitalization, recovery and death rates  
Research in New York showed 48.7% of COVID-19 
patients had been hospitalized among 4,103 cases (Table 
3). The highest hospitalization rate was seen among 
patients aged 65-74 (OR of 10.9, and aged ≥75 years 
(OR of 66.8); with an odds ratio of 6.2, and 4.3 among 
patients with obesity (BMI>40) and heart failure 
respectively  (10). A CDC COVID-19 response team 
reported that hospitalization rate ranges from 20.7% to 
31.4% among 2,449 patients in USA; less than 1% of 
hospitalizations, among people aged 19 years, from 2%-
3% among people aged about 19 -60 years and about 










79     Ethiop. J. Health Dev. 
 
Ethiop. J. Health Dev.2021; 35(SI-1) 
 
Table 3: Characteristics of the studies  
























Chen N et al  2020 99 55 67.7  31 11   
Garg S et al  2020 1482 NR 54 0.0046     
Guan W et al  2020 1099 47 58.1   1.4 -/5/2.3 4 
Lauer SA et al  2020 181 44.5 59.7     5.1 




Petrilli CM 2020 4103 52 50.49 48.7 49.1 14.6   
Wu Z et al 2020 72,314 NR NR   2.3 81/14/5  
Giacomelli A 
et al 
2020 233 61 69.1  69.5 20.6   
Li X et al 2020 548 60 50.9    -/49.1/-  
Shim E et al 2020 6284    1.72 0.7   
Ye Q. et al 2020 1099 47 58.2   4 -/-/23.4 5.2 
Nie X et al 2020 7015 44.24 
mean 
54.12     5 
Kong T-k 2020 136 50.5 53     8.3  
The discharge rate among hospitalized patients in New 
York City, Italy, China and South Korea were 49.1% 
(10), 31% (12), 69.5 percent(13), and 72% (14) 
respectively. 
 
The overall death rate among the 1,999 hospitalized 
patients in New York City was 14.6%; and 36.4% 
among ventilated patients (10). However, the case-
specific fatality rates were 8.0% among patients aged 70 
to 79, 14.8% aged over 80, and 49.0% in critical cases 
(15).  
 
The case-fatality ratio in Wuhan was 4.5% while for 
those outside was 3.2% (16). Death ratio was 4.2, 20.6 
and 0.7%  in Wuhan's, in the rest of China(17), in Italy 
(13), and in South Korean (14) respectively. This study 
indicated the crude case fatality rate for males (1.1%) 
and females (0.4%) (14). More than 80% of those died 
were over 60 years old and more than 75% of the deaths 
had underlying diseases.  
 
Incubation period 
A study conducted in 181 confirmed cases in China 
showed an estimated median incubation period of 5.1 
days and 97.5% of them developed symptoms within 
11.5 days of infection(18);  another study from 1099 
patients showed the median incubation period of 4 days 
(interquartile range, 2 to 7)(19) (Table 3). For 1 case the 
longest period of incubation was 24 days. The 
incubation period was less than 13 days for more than 
95% of COVID-19 cases (20). However, the incubation 
period varied by age (21). 
 
Severity of Disease 
A report from the USA CDC indicated that 31% of 
cases, 45% of hospitalizations, 53% of ICU admissions, 
and 80% of deaths associated with COVID-19 were 
among adults aged ≥65 years(Table 3). The highest 
percentage of severe outcomes were observed among 
persons aged ≥85 years (11). The strongest critical 
illness risks were observed among  
patients with admission of oxygen saturation <88%  (OR 
6.99, d-dimer>2500 (OR 6.9), ferritin >2500 (OR 6.9), 
and C-reactive protein (CRP) >200 (OR 5.78) (10). 
 
The Chinese CDC report from 72, 314 cases showed the 
severity condition of COVID-19 cases as 81% mild, 
14% severe and 5% critical (15); with 23.7 percent 
having at least one coexisting disease.  
 
During the peak epidemic in Wuhan, 0.122% of patients 
were in severe condition, and 0.026% needed critical 
care per day(16). Severe cases were higher in males than 
females (56.9% vs 45.2%; P =.006) (22).  
 
Discussion  
Since the first case reported on March 13, 2020, there 
are 5,689 confirmed cases, 2,132 recovered cases and 98 
deaths in Ethiopia as of June 24, 2020 (23). The COVID-
19 pandemic is currently affecting the health, social and 
economic affair of many countries. Ethiopia is striving 
to fight the disease using policy measures including state 
emergency, community mobilization, and clinical and 
epidemiological interventions. Understanding the 
clinical and epidemiological characteristics of the 
disease is crucial to mitigate its catastrophic effect by 
prevention and control. In this regard, the current 
systematic review is helpful to learn lesson and 
understand the characteristics of the disease associated 
with its spread and severity. This review focused on 
hospitalization, recovery and death rates as well as the 
incubation and severity of the disease.  
 
Hospitalization rate varied by geospatial conditions and 
by demographic characteristics of patients (10, 11, 24). 
The possible reasons for the variation from place to 
place might be due to the governments measure like 
national and local lockdown, school and public places 
closure, enforcement of physical distancing and 
facemask use. Most studies consistently reported the 
older ages and males have a higher risk of 
hospitalization. Understanding these concepts are 
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important for early preparedness and planning (28-32).  
The proportion of recovery or discharge of patients was 
different in different studies (10, 12-14). 
  
Most of the studies calculated the death rate of COVID-
19 from reported confirmed cases rather than the actual 
cases which are typically larger than the reported 
confirmed cases (25). This may overestimate the death 
rate in most instances as most of asymptomatic and mild 
cases remain undetected. The studies showed the death 
rate widely ranged with different characteristics of 
patients (10, 11, 13-17). In most of the studies, the 
overall mortality rate was relatively low compared with 
age, sex, level of severity and underlying disease-
specific mortality. Patients who were critically ill, under 
mechanical ventilation, and in ICU were at the highest 
rate of death. Patients over 60 were at a higher risk of 
death compared with younger age patients. 
  
The overall median incubation period of COVID-19 was 
a little bit varying among several studies (18-21). 
However, there were instances that the incubation 
period specifically longer than the majority group in 
some cases (20).  The incubation period also varied by 
age that patients with older age had a longer incubation 
period (21). Knowing the incubation period of COVID-
19 is important for disease surveillance, prevention and 
control measures of the disease. Although most studies 
suggested the 14 days incubation period, there are 
evidences that the incubation period extends to 24 days.  
 
Most studies indicated that severity of COVID-19 is 
associated with factors like age, sex, chronic underlying 
illness, co-infection of bacteria and fungi and clinical 
factors like d-dimer, ferritin, C-reactive protein and 
leukocytosis (10-12, 16, 17, 19). The studies also 
indicated the proportion of mild, moderate and critical 
cases of the disease (15). 
  
Conclusion  
The proportion of hospitalization is significantly higher 
in older age and male patients globally. The recovery or 
discharge rate of hospitalized patients varied from place 
to place. The older age, male, critically ill and chronic 
disease patients were at higher risk of death. Patients 
with older age have a prolonged incubation period. The 
important predictors of COVID-19 severity were age, 
sex, presence of chronic illness, and clinical factors like 
d-dimer, ferritin, C-reactive protein and leukocytosis.  
 
Recommendations    
The Federal Ministry of Health and Addis Ababa City 
Administration should strengthen the intervention 
measures to contain the spread of the disease in Addis 
Ababa and to limit its spread to other regions of the 
country. 
  
Health care facilities should give special focus for 
people of older ages, having underlying and chronic 
disease in prevention and clinical interventions. 
 
Limitation of the study  
This review didn’t include studies from Africa and 
Ethiopia since we cannot find published or preprint 
study at the time of our review. This review is a 
qualitative synthesis that cannot show the statistical 
significance of the issues described.  
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